Your browser is no longer supported. Please, upgrade your browser.
Settings
LJPC La Jolla Pharmaceutical Company daily Stock Chart
LJPC [NASD]
La Jolla Pharmaceutical Company
Index- P/E- EPS (ttm)-7.17 Insider Own0.30% Shs Outstand25.51M Perf Week-5.32%
Market Cap449.49M Forward P/E- EPS next Y-4.67 Insider Trans2.68% Shs Float24.84M Perf Month-16.69%
Income-168.10M PEG- EPS next Q-2.01 Inst Own- Short Float40.66% Perf Quarter-41.94%
Sales2.40M P/S187.29 EPS this Y-19.20% Inst Trans0.11% Short Ratio19.77 Perf Half Y-43.18%
Book/sh4.16 P/B4.24 EPS next Y42.80% ROA-94.80% Target Price56.40 Perf Year-49.77%
Cash/sh9.46 P/C1.86 EPS next 5Y13.20% ROE-148.00% 52W Range17.01 - 41.36 Perf YTD-45.25%
Dividend- P/FCF- EPS past 5Y33.50% ROI- 52W High-57.40% Beta1.19
Dividend %- Quick Ratio13.00 Sales past 5Y- Gross Margin92.20% 52W Low3.57% ATR1.00
Employees130 Current Ratio13.00 Sales Q/Q- Oper. Margin- RSI (14)32.13 Volatility6.54% 5.12%
OptionableYes Debt/Eq0.00 EPS Q/Q-66.80% Profit Margin- Rel Volume1.81 Prev Close17.14
ShortableYes LT Debt/Eq0.00 EarningsNov 07 AMC Payout- Avg Volume510.73K Price17.62
Recom2.80 SMA20-11.14% SMA50-21.88% SMA200-39.78% Volume908,032 Change2.80%
Feb-12-18Downgrade Jefferies Buy → Underperform
Jan-25-18Reiterated Chardan Capital Markets Neutral $90 → $100
Dec-26-17Reiterated SunTrust Buy $57 → $65
Dec-22-17Reiterated SunTrust Buy $67 → $65
Dec-22-17Reiterated H.C. Wainwright Buy $62 → $91
Dec-21-17Initiated H.C. Wainwright Buy $62
Dec-08-17Downgrade JP Morgan Overweight → Underweight
Aug-30-17Initiated JP Morgan Overweight $36
Feb-27-17Reiterated SunTrust Buy $38 → $57
Jun-22-16Initiated SunTrust Buy $30
May-24-16Initiated Lake Street Buy $25
Sep-08-15Reiterated Chardan Capital Markets Buy $60 → $80
Jul-07-15Reiterated Chardan Capital Markets Buy $54 → $60
May-11-15Reiterated H.C. Wainwright Buy $29 → $20
Apr-21-15Initiated Oppenheimer Outperform $43
Mar-20-15Reiterated H.C. Wainwright Buy $20 → $29
Mar-02-15Resumed Chardan Capital Markets Buy $54
Jul-09-14Reiterated Noble Financial Buy $34 → $38
May-05-14Initiated H.C. Wainwright Buy $17
Mar-11-14Reiterated Noble Financial Buy $16 → $34
Aug-16-18 08:00AM  Factors of Influence in 2018, Key Indicators and Opportunity within Celsion, Alpha and Omega Semiconductor, SP Plus, Merrimack Pharmaceuticals, La Jolla Pharmaceutical, and SPX New Research Emphasizes Economic Growth GlobeNewswire +9.10%
Aug-13-18 03:35PM  Edited Transcript of LJPC earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-18 12:51PM  Why La Jolla Pharmaceutical Is Tumbling Today Motley Fool -25.39%
Aug-08-18 08:00PM  La Jolla Pharmaceutical (LJPC) Reports Q2 Loss, Misses Revenue Estimates Zacks +5.47%
06:55PM  La Jolla Pharmaceutical: 2Q Earnings Snapshot Associated Press
04:01PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Corporate Progress GlobeNewswire
02:30PM  La Jolla Pharmaceutical Company to Host Earnings Call ACCESSWIRE
Aug-03-18 09:00AM  La Jolla Pharmaceutical Company Announces Receipt of New Technology Add-on Payment Coverage for GIAPREZA GlobeNewswire
Aug-01-18 05:39PM  La Jolla Pharmaceutical Company to Release Second Quarter 2018 Financial Results and Host a Webcasted Conference Call on August 8, 2018 GlobeNewswire
Jul-16-18 07:05AM  Free Technical Research on Marinus Pharma and Three More Biotech Equities ACCESSWIRE
Jun-25-18 09:00AM  La Jolla Pharmaceutical Company Announces European Medicines Agency Validation of Marketing Authorisation Application for GIAPREZA (angiotensin II) GlobeNewswire
Jun-15-18 02:39PM  2 Stable and 2 Speculative Biotech Stocks to Buy InvestorPlace
07:09AM  Iovance Biotherapeutics and Three Additional Biotech Stocks on Our Research Desk's Radar ACCESSWIRE
May-21-18 08:25AM  Recent Analysis Shows Engility, La Jolla Pharmaceutical, Freshpet, At Home Group, Denny's, and SP Plus Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
May-17-18 01:00PM  La Jolla Pharmaceutical Company Announces LJPC-401 Presentations at 23rd Congress of the European Hematology Association GlobeNewswire
May-11-18 07:05AM  Complimentary Stock Performance Review on La Jolla Pharma and Three Additional Biotech Industry Stocks ACCESSWIRE -6.58%
May-10-18 09:23PM  What Should We Expect From La Jolla Pharmaceutical Companys (NASDAQ:LJPC) Earnings In The Next Couple Of Years? Simply Wall St.
07:53PM  La Jolla Pharmaceutical: 1Q Earnings Snapshot Associated Press
04:46PM  La Jolla Pharmaceutical Company Announces $125 Million Royalty Financing Agreement with HealthCare Royalty Partners GlobeNewswire
04:45PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress GlobeNewswire
May-01-18 05:15PM  CalciMedica Names Two Senior Executives to its Board of Directors PR Newswire
Mar-30-18 08:00AM  [$$] 3 Biotech Stocks a Pro Is Buying Now Barrons.com
Mar-23-18 07:40AM  Market Trends Toward New Normal in La Jolla Pharmaceutical, AquaVenture, Duluth, Community Bank System, Cubic, and TrustCo Bank Corp NY Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Mar-22-18 04:01PM  La Jolla Pharmaceutical Company Announces Launch of GIAPREZA (angiotensin II) in the United States GlobeNewswire
Mar-15-18 08:00AM  La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock GlobeNewswire
Mar-14-18 04:01PM  La Jolla Pharmaceutical Company Announces $100 Million Public Offering of Common Stock GlobeNewswire -8.21%
Mar-06-18 02:40PM  GIAPREZA (angiotensin II) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury GlobeNewswire
Feb-25-18 09:00AM  GIAPREZA (angiotensin II) Significantly Improved Survival of Patients with High APACHE II Scores in ATHOS-3 Study GlobeNewswire
Feb-23-18 05:02AM  La Jolla Pharmaceutical posts 4Q loss Associated Press
Feb-22-18 05:17PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress GlobeNewswire
Feb-21-18 09:00AM  La Jolla Pharmaceutical Company Announces the Treatment of First Patient in GIAPREZA (angiotensin II) Pediatric Study GlobeNewswire
Feb-12-18 04:35PM  Why Lumber Liquidators Holdings, Stamps.com, and La Jolla Pharmaceutical Slumped Today Motley Fool -13.09%
11:04AM  Jefferies Downgrades La Jolla On Weak Forecast For Blood Pressure Drug Benzinga
Feb-02-18 02:39PM  What You Must Know About La Jolla Pharmaceutical Companys (NASDAQ:LJPC) Financial Health Simply Wall St. +7.67%
Jan-24-18 08:00AM  Consolidated Research: 2018 Summary Expectations for Freshpet, eHealth, SEACOR, La Jolla Pharmaceutical, Rogers, and On Assignment Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-03-18 03:00AM  La Jolla Pharmaceutical Hits 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Dec-29-17 09:00PM  3 Biotechs Launching Their First Commercial Drugs in 2018 Motley Fool
Dec-28-17 07:19AM  La Jolla Pharmaceutical Co. is trading above its 50 day moving average : LJPC-US : December 28, 2017 Capital Cube
Dec-26-17 08:36AM  La Jolla Pharmaceutical (LJPC) Surges: Stock Moves 11.1% Higher Zacks
Dec-22-17 04:13PM  Christmas Comes Early For These 5 Biotechnology Stocks Investor's Business Daily +11.13%
12:20PM  What the Latest Approval Means for La Jolla Pharmaceutical GuruFocus.com
12:16PM  Here's Why La Jolla Pharmaceutical Shares Are Surging 12.5% Higher Today Motley Fool
Dec-21-17 06:36PM  La Jolla stock jumps 16% after FDA approval MarketWatch
06:35PM  FDA approves La Jolla's low blood pressure drug Reuters
06:15PM  La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza (angiotensin II) GlobeNewswire
11:58AM  Analyst: La Jolla Pharma A Buy Ahead Of February FDA Date Benzinga
Dec-19-17 05:35AM  [$$] 5 Biotech Stocks a Pro Is Buying Barrons.com
Dec-18-17 09:00AM  La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC401 in Patients with Hereditary Hemochromatosis GlobeNewswire
Dec-11-17 08:10AM  Todays Research Reports on Stocks to Watch: Soleno Therapeutics and La Jolla Pharmaceutical Company ACCESSWIRE
Dec-08-17 01:54PM  Here's What's Causing Investors to Sell La Jolla Pharmaceutical Shares Today Motley Fool -15.03%
Dec-04-17 09:00AM  La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC401 in Patients with Beta Thalassemia GlobeNewswire
Nov-20-17 07:57AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : November 20, 2017 Capital Cube
Nov-08-17 01:43PM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : November 8, 2017 Capital Cube
Oct-30-17 03:00AM  La Jolla Pharmaceutical Earns Relative Strength Rating Upgrade Investor's Business Daily
Oct-26-17 05:19PM  La Jolla Pharmaceutical posts 3Q loss Associated Press
05:10PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress Business Wire
11:07AM  La Jolla Pharmaceutical Co. Value Analysis (NASDAQ:LJPC) : October 26, 2017 Capital Cube
Oct-25-17 08:15AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : October 25, 2017 Capital Cube
Sep-27-17 07:30AM  Featured Company News - La Jolla Pharma Announces Intent to Submit MAA for LJPC-501, or Angiotensin II ACCESSWIRE
Sep-25-17 06:30AM  La Jolla Pharmaceutical Company Announces Intent to Submit Marketing Authorization Application for LJPC-501 in the Third Quarter of 2018 Business Wire
Sep-20-17 04:50PM  Prespecified Analysis of ATHOS-3 Indicates Survival Benefit in LJPC-501-Treated Patients with Relatively Low Angiotensin II State Business Wire
Sep-15-17 09:44AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : September 15, 2017 Capital Cube
Aug-28-17 09:00AM  La Jolla Pharmaceutical Company Announces U.S. FDA Acceptance of New Drug Application for LJPC-501 Business Wire +10.33%
Aug-25-17 08:39AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : August 25, 2017 Capital Cube
Aug-24-17 07:50AM  Corporate News Blog - Insys Therapeutics Releases Statement on Illinois Settlement; Provides Data against the Opioid-Induced Calamity in the US ACCESSWIRE +5.55%
Aug-14-17 05:58PM  La Jolla Pharmaceutical Co. Value Analysis (NASDAQ:LJPC) : August 14, 2017 Capital Cube
Aug-11-17 10:09AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : August 11, 2017 Capital Cube
Aug-08-17 09:00AM  La Jolla Pharmaceutical Company Announces Launch of Expanded Access Program for LJPC-501 Business Wire
Jul-31-17 09:59AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : July 31, 2017 Capital Cube
Jul-27-17 10:40PM  La Jolla Pharmaceutical posts 2Q loss Associated Press
04:00PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress Business Wire
Jul-24-17 05:00PM  ETFs with exposure to La Jolla Pharmaceutical Co. : July 24, 2017 Capital Cube
Jul-14-17 03:20PM  ETFs with exposure to La Jolla Pharmaceutical Co. : July 14, 2017 Capital Cube
Jun-22-17 08:08AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : June 22, 2017 Capital Cube
Jun-15-17 02:25PM  ETFs with exposure to La Jolla Pharmaceutical Co. : June 15, 2017 Capital Cube
Jun-08-17 08:23AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : June 8, 2017 Capital Cube
May-29-17 08:21AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : May 29, 2017 Capital Cube
May-22-17 07:13AM  Mixed Outcomes for La Jolla Pharma Shock Drug Fuels Debate Over Sales Potential TheStreet.com
May-21-17 01:10PM  Results of ATHOS-3 Phase 3 Study of LJPC-501 Published in The New England Journal of Medicine Business Wire
May-19-17 08:43AM  Implied Volatility Surging for La Jolla Pharmaceutical (LJPC) Stock Options Zacks
08:17AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : May 19, 2017 Capital Cube
May-18-17 04:37PM  Here's Why La Jolla Pharmaceuticals Company Is Soaring Motley Fool +23.88%
Apr-27-17 06:16PM  La Jolla Pharmaceutical posts 1Q loss Associated Press
04:10PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress Business Wire
Apr-24-17 03:33PM  La Jolla Pharmaceutical Co. Value Analysis (NASDAQ:LJPC) : April 24, 2017 Capital Cube
Apr-21-17 08:46AM  La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : April 21, 2017 Capital Cube
Mar-24-17 06:04AM  LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E
Mar-23-17 08:00AM  La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock Business Wire
Mar-20-17 04:11PM  LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits +7.13%
04:01PM  La Jolla Pharmaceutical Company Announces Proposed Underwritten Public Offering of Common Stock Business Wire
11:25AM  Biotechs Remain the Best Place For Stock Picking TheStreet.com
11:25AM  Biotechs Remain the Best Place For Stock Picking
Mar-10-17 09:53AM  La Jolla Pharmaceutical (LJPC) is in Overbought Territory: What's Next? Zacks
Mar-07-17 01:25PM  La Jolla Pharmaceutical Co. :LJPC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Capital Cube
01:25PM  La Jolla Pharmaceutical Co. :LJPC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
10:20AM  Biotech Bounce Set to Pick Up Steam Investopedia
Mar-01-17 01:04PM  LA JOLLA PHARMACEUTICAL CO Financials
Feb-28-17 06:30PM  LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:40AM  6 Stocks on the Move With Unusual Volume TheStreet.com
10:40AM  6 Stocks on the Move With Unusual Volume
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. It offers GIAPREZA, an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock. The company is developing LJPC-401, a formulation of synthetic human hepcidin for the treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease, and myelodysplastic syndrome. La Jolla Pharmaceutical Company was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARVER JENNIFERChief Operating OfficerAug 16Buy20.901,00020,8956,500Aug 20 09:05 PM
Rolke JamesChief Scientific OfficerAug 16Buy22.001,00021,99774,328Aug 20 09:06 PM
Douglass Laura L.DirectorMay 30Option Exercise6.005003,000500Jun 01 09:12 PM
TANG KEVIN CDirectorMar 15Buy29.50508,47414,999,9834,138,893Mar 19 08:15 PM
PERCEPTIVE ADVISORS LLC10% OwnerMar 15Buy29.50700,00020,650,0004,313,611Mar 26 04:59 PM
TANG KEVIN CDirectorMar 02Buy30.4410,000304,4353,630,419Mar 02 05:56 PM
TANG KEVIN CDirectorFeb 28Buy29.9430,000898,0923,620,419Mar 02 05:56 PM
CARVER JENNIFERChief Operating OfficerFeb 23Buy32.481,00032,4755,500Feb 27 09:00 PM
PERCEPTIVE ADVISORS LLC10% OwnerFeb 15Buy32.4250,0001,621,0003,613,611Feb 20 04:19 PM
PERCEPTIVE ADVISORS LLC10% OwnerFeb 14Buy32.69100,0003,269,0003,563,611Feb 15 04:17 PM
PERCEPTIVE ADVISORS LLC10% OwnerFeb 13Buy32.7575,0002,456,2503,463,611Feb 15 04:17 PM
Douglass Laura L.DirectorDec 29Option Exercise8.9010,00089,04010,000Jan 03 09:55 PM
Douglass Laura L.DirectorDec 29Sale32.3210,000323,2080Jan 03 09:55 PM
CARVER JENNIFERChief Operating OfficerDec 27Buy33.221,00033,2154,500Dec 29 05:07 PM